Serum Osteopontin as a Novel Biomarker for Muscle Regeneration in Duchenne Muscular Dystrophy
Mutsuki Kuraoka(National Center of Neurology and Psychiatry), Shin’ichi Takeda(Kushiro City General Hospital)
Cited by 38
Related Papers
Merosin and congenital muscular dystrophy
|Microscopy Research and Technique|2000|108
Characterization of a novel microRNA, miR-188, elevated in serum of muscular dystrophy dog model
|PLoS ONE|2019|15
Enhancement of Satellite Cell Transplantation Efficiency by Leukemia Inhibitory Factor
|Journal of Neuromuscular Diseases|2016|14